Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | MRNA | BMY | AMGN | GILD |
| Company | Argenx Se ADR | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 370.82 | 106.18 | 44.68 | 265.72 | 65.50 |
| High | 375.80 | 108.15 | 45.34 | 271.68 | 66.35 |
| Low | 366.72 | 105.25 | 44.34 | 265.72 | 64.63 |
| Last | 373.71 | 106.74 | 45.20 | 269.61 | 65.60 |
| Change | +5.11 | +0.56 | +0.50 | +0.23 | +0.33 |
| % Change | +1.39% | +0.53% | +1.12% | +0.09% | +0.51% |
| Volume | 57,873 | 467,392 | 5,153,184 | 343,807 | 4,368,470 |
| 20-Day Average Volume | 213,230 | 2,962,271 | 12,373,589 | 2,050,966 | 6,642,376 |
| Previous Close | 368.60 | 106.18 | 44.70 | 269.38 | 65.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 378.59 | 105.02 | 49.49 | 269.98 | 68.29 |
| 20-Day Raw Stochastic | 39.75% | 53.16% | 9.20% | 39.35% | 9.78% |
| 20-Day Relative Strength | 46.31% | 53.99% | 31.29% | 45.29% | 29.51% |
| Weighted Alpha | -23.55 | -10.45 | -33.59 | +9.36 | -23.41 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
| Last Month's Opinion | 64% Sell | 72% Buy | 8% Buy | 40% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.93% since 04/19/24 | +5.55% since 04/19/24 | -7.52% since 04/19/24 | +0.33% since 04/19/24 | -1.93% since 04/19/24 |
| Low | 359.83 on 04/22/24 | 99.30 on 04/22/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 |
| High | 380.85 on 04/24/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | -5.83% since 03/26/24 | -0.34% since 03/26/24 | -13.89% since 03/26/24 | -4.24% since 03/26/24 | -9.58% since 03/26/24 |
| Low | 357.55 on 04/19/24 | 97.00 on 04/03/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 |
| High | 400.21 on 03/27/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -2.14% since 01/26/24 | +5.14% since 01/26/24 | -8.95% since 01/26/24 | -13.46% since 01/26/24 | -17.67% since 01/26/24 |
| Low | 349.86 on 03/20/24 | 84.06 on 02/13/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 |
| High | 413.10 on 02/23/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 |
| 6-Month | |||||
| %Chg | -20.41% since 10/26/23 | +40.88% since 10/26/23 | -14.57% since 10/26/23 | +0.04% since 10/26/23 | -16.60% since 10/26/23 |
| Low | 327.73 on 12/21/23 | 62.55 on 11/02/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 |
| High | 506.92 on 11/08/23 | 115.97 on 01/08/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 21,906,262 | 40,654,200 | 90,596,128 | 144,488,960 | 81,266,176 |
| Shares Outstanding, K | 59,431 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 1,268,590,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -295,050,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 417,960,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -99,170,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.65 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.68 on 02/29/24 | 0.55 on 02/22/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.51 | 14.64 | 9.98 |